{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.4:c.137G>A",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "G",
            "alt": "A",
            "position": "137"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "46"
          },
          "Description in input context": "c.137G>A (p.E46K)"
        },
        {
          "HGVS": "NM_000345.4:c.158A>T",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "A",
            "alt": "T",
            "position": "158"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "V",
            "position": "53"
          },
          "Description in input context": "c.158A>T (p.A53T)"
        },
        {
          "HGVS": "NM_000345.4:c.137G>C",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "G",
            "alt": "C",
            "position": "137"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "A",
            "position": "46"
          },
          "Description in input context": "c.137G>C (p.E46A)"
        },
        {
          "HGVS": "NM_000345.4:c.248A>C",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "A",
            "alt": "C",
            "position": "248"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "A",
            "position": "83"
          },
          "Description in input context": "c.248A>C (p.E83A)"
        },
        {
          "HGVS": "NM_000345.4:c.248A>G",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "A",
            "alt": "G",
            "position": "248"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "83"
          },
          "Description in input context": "c.248A>G (p.E83K)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease (PD) / Dementia with Lewy bodies (DLB)",
    "MONDO": "MONDO:0005072"
  },
  "Experiment Method": [
    {
      "Assay Method": "Filament Assembly and Centrifugal Sedimentation",
      "Material used": {
        "Material Source": "Recombinant Protein",
        "Material Name": "Recombinant SNCA proteins",
        "Description": "Human SNCA cDNA was cloned into the NdeI and HindIII restriction sites of the bacterial expression vector pRK172. The cDNAs coding for the mutant SNCA proteins E46A, E46K, E83A, and E83K were engineered by creating the corresponding nucleotide substitutions in the wild-type cDNA."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.137G>A",
          "Conclusion": "Increased",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The E46K mutation increased the propensity of SNCA to fibrillize compared with the WT protein."
        },
        {
          "Variant": "NM_000345.4:c.158A>T",
          "Conclusion": "Increased",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The A53T mutation increased the propensity of SNCA to fibrillize to a greater extent than the E46K mutation."
        },
        {
          "Variant": "NM_000345.4:c.137G>C",
          "Conclusion": "Increased",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The E46A mutation increased the propensity to polymerize, but this substitution resulted in two types of mature fibrils."
        },
        {
          "Variant": "NM_000345.4:c.248A>C",
          "Conclusion": "Increased",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The E83A mutation increased the ability of SNCA to polymerize, but the resulting filaments showed reduced characteristics of true amyloid."
        },
        {
          "Variant": "NM_000345.4:c.248A>G",
          "Conclusion": "Increased",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The E83K mutation increased the ability of SNCA to polymerize, but the resulting filaments showed reduced characteristics of true amyloid."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "All experiments were conducted multiple times."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Samples were run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type SNCA protein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Buffer without protein was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "5"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Densitometry of Coomassie Blue-stained SDS-polyacrylamide gels or 125I quantitative Western blotting analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "K114 Fluorometry",
      "Material used": {
        "Material Source": "Recombinant Protein",
        "Material Name": "Recombinant SNCA proteins",
        "Description": "Human SNCA cDNA was cloned into the NdeI and HindIII restriction sites of the bacterial expression vector pRK172. The cDNAs coding for the mutant SNCA proteins E46A, E46K, E83A, and E83K were engineered by creating the corresponding nucleotide substitutions in the wild-type cDNA."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.137G>A",
          "Conclusion": "Increased",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The E46K mutant polymerized more readily than the WT protein."
        },
        {
          "Variant": "NM_000345.4:c.158A>T",
          "Conclusion": "Increased",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The A53T mutation increased the propensity of SNCA to fibrillize to a greater extent than the E46K mutation."
        },
        {
          "Variant": "NM_000345.4:c.137G>C",
          "Conclusion": "Increased",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The E46A mutation increased the propensity to polymerize, but this substitution resulted in two types of mature fibrils."
        },
        {
          "Variant": "NM_000345.4:c.248A>C",
          "Conclusion": "Increased",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The E83A mutation increased the ability of SNCA to polymerize, but the resulting filaments showed reduced characteristics of true amyloid."
        },
        {
          "Variant": "NM_000345.4:c.248A>G",
          "Conclusion": "Increased",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The E83K mutation increased the ability of SNCA to polymerize, but the resulting filaments showed reduced characteristics of true amyloid."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "All experiments were conducted multiple times."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Samples were run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type SNCA protein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Buffer without protein was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "5"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Fluorescence measurement with a SpectraMax Gemini fluorometer and SoftMax Pro 4.0 software."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "CD Spectrometry",
      "Material used": {
        "Material Source": "Recombinant Protein",
        "Material Name": "Recombinant SNCA proteins",
        "Description": "Human SNCA cDNA was cloned into the NdeI and HindIII restriction sites of the bacterial expression vector pRK172. The cDNAs coding for the mutant SNCA proteins E46A, E46K, E83A, and E83K were engineered by creating the corresponding nucleotide substitutions in the wild-type cDNA."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.137G>A",
          "Conclusion": "Increased",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The E46K mutation converted from random coil conformation to β-sheet more readily than the WT protein."
        },
        {
          "Variant": "NM_000345.4:c.158A>T",
          "Conclusion": "Increased",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The A53T mutation increased the propensity of SNCA to fibrillize to a greater extent than the E46K mutation."
        },
        {
          "Variant": "NM_000345.4:c.137G>C",
          "Conclusion": "Increased",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The E46A mutation increased the propensity to polymerize, but this substitution resulted in two types of mature fibrils."
        },
        {
          "Variant": "NM_000345.4:c.248A>C",
          "Conclusion": "Increased",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The E83A mutation increased the ability of SNCA to polymerize, but the resulting filaments showed reduced characteristics of true amyloid."
        },
        {
          "Variant": "NM_000345.4:c.248A>G",
          "Conclusion": "Increased",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The E83K mutation increased the ability of SNCA to polymerize, but the resulting filaments showed reduced characteristics of true amyloid."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "All experiments were conducted multiple times."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Samples were run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type SNCA protein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Buffer without protein was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "5"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "CD spectra were recorded using an Aviv model 202 spectrophotometer."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "ATR-FTIR Spectroscopy",
      "Material used": {
        "Material Source": "Recombinant Protein",
        "Material Name": "Recombinant SNCA proteins",
        "Description": "Human SNCA cDNA was cloned into the NdeI and HindIII restriction sites of the bacterial expression vector pRK172. The cDNAs coding for the mutant SNCA proteins E46A, E46K, E83A, and E83K were engineered by creating the corresponding nucleotide substitutions in the wild-type cDNA."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.137G>A",
          "Conclusion": "Increased",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The E46K mutation converted from random coil conformation to β-sheet more readily than the WT protein."
        },
        {
          "Variant": "NM_000345.4:c.158A>T",
          "Conclusion": "Increased",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The A53T mutation increased the propensity of SNCA to fibrillize to a greater extent than the E46K mutation."
        },
        {
          "Variant": "NM_000345.4:c.137G>C",
          "Conclusion": "Increased",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The E46A mutation increased the propensity to polymerize, but this substitution resulted in two types of mature fibrils."
        },
        {
          "Variant": "NM_000345.4:c.248A>C",
          "Conclusion": "Increased",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The E83A mutation increased the ability of SNCA to polymerize, but the resulting filaments showed reduced characteristics of true amyloid."
        },
        {
          "Variant": "NM_000345.4:c.248A>G",
          "Conclusion": "Increased",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The E83K mutation increased the ability of SNCA to polymerize, but the resulting filaments showed reduced characteristics of true amyloid."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "All experiments were conducted multiple times."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Samples were run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type SNCA protein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Buffer without protein was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "5"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ATR-FTIR spectra were collected on a Digilab FTS-60A equipped with a wide band MCT detector."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Negative Staining EM",
      "Material used": {
        "Material Source": "Recombinant Protein",
        "Material Name": "Recombinant SNCA proteins",
        "Description": "Human SNCA cDNA was cloned into the NdeI and HindIII restriction sites of the bacterial expression vector pRK172. The cDNAs coding for the mutant SNCA proteins E46A, E46K, E83A, and E83K were engineered by creating the corresponding nucleotide substitutions in the wild-type cDNA."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.137G>A",
          "Conclusion": "Increased",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The E46K mutant protein had a tendency to form compact bundles of fibrils."
        },
        {
          "Variant": "NM_000345.4:c.158A>T",
          "Conclusion": "Increased",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The A53T mutation increased the propensity of SNCA to fibrillize to a greater extent than the E46K mutation."
        },
        {
          "Variant": "NM_000345.4:c.137G>C",
          "Conclusion": "Increased",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The E46A mutation increased the propensity to polymerize, but this substitution resulted in two types of mature fibrils."
        },
        {
          "Variant": "NM_000345.4:c.248A>C",
          "Conclusion": "Increased",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The E83A mutation increased the ability of SNCA to polymerize, but the resulting filaments showed reduced characteristics of true amyloid."
        },
        {
          "Variant": "NM_000345.4:c.248A>G",
          "Conclusion": "Increased",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The E83K mutation increased the ability of SNCA to polymerize, but the resulting filaments showed reduced characteristics of true amyloid."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "All experiments were conducted multiple times."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Samples were run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type SNCA protein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Buffer without protein was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "5"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Images were captured with a Hamamatsu digital camera using AMT software."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}